Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share of Common Stock (Details Narrative)

v3.21.1
Net Loss Per Share of Common Stock (Details Narrative) - shares
6 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Stock Options [Member]    
Antidilutive shares 8,813,626 8,382,234
Warrants [Member]    
Antidilutive shares 860,000 500,000